You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FGF23

Showing 1 - 25 of 438
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibroblast Growth Factor 23, Anemia, CKD Trial in Córdoba

Active, not recruiting
  • Fibroblast Growth Factor 23
  • +2 more
    • Córdoba, Spain
      Hospital Universitario Reina Sofia
    Apr 27, 2022

    X-linked Hypophosphatemia Trial in Würzburg (Burosumab)

    Active, not recruiting
    • X-linked Hypophosphatemia
    • Würzburg, Germany
      Clinical Trial Unit, Orthopedic Department, Wuerzburg University
    Apr 26, 2022

    Inappropriate Secretion of FGF23 in Patients Followed in

    Recruiting
    • Hypophosphatemia Without Immediate Anteriority
    • Unexplained Hypophosphatemia
    • unexplained hypophoshatemia
    • Clermont-Ferrand, France
    • +1 more
    Mar 10, 2022

    Diabetes, Type 2, Kidney Diseases Trial in Amman (Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol)

    Completed
    • Diabetes Mellitus, Type 2
    • Kidney Diseases
    • Soft gelatin capsules each contains 50 000 IU VD3 (cholecalciferol) equivalents to 1.25 mg.
    • Amman, Jordan
      Mahmoud S Abu-Samak
    Feb 23, 2022

    Tumor-Induced Osteomalacia (TIO) Trial in Beijing, Chengdu, Shanghai (KRN23)

    Recruiting
    • Tumor-Induced Osteomalacia (TIO)
    • Beijing, China
    • +2 more
    Sep 10, 2022

    Chronic Kidney Disease Requiring Chronic Dialysis Trial in Vienna

    Completed
    • Chronic Kidney Disease Requiring Chronic Dialysis
      • Vienna, Austria
        Medical University of Vienna
      Sep 1, 2021

      X-linked Hypophosphatemia (XLH) Trial in Beijing, Guangzhou, Shanghai (KRN23)

      Recruiting
      • X-linked Hypophosphatemia (XLH)
      • Beijing, China
      • +2 more
      Nov 10, 2021

      X-linked Hypophosphatemia (XLH) Trial in China (KRN23)

      Recruiting
      • X-linked Hypophosphatemia (XLH)
      • Beijing, China
      • +4 more
      Nov 10, 2021

      Tumor Induced Osteomalacia (TIO), Epidermal Nevus Syndrome (ENS) Trial in United States (Burosumab)

      Completed
      Has Results
      • Tumor Induced Osteomalacia (TIO)
      • Epidermal Nevus Syndrome (ENS)
      • Burosumab
      • Golden, Colorado
      • +6 more
      Jan 20, 2022

      FGF23 as a Marker of Acute Kidney Injury

      Recruiting
      • Acute Kidney Injury
      • Kidney Ischemia
      • Plasmatic Fibroblast Growth Factor-23 by means of ELISA
      • Santiago, Chile
        Hospital Clinic Universidad de Chile
      Dec 30, 2020

      Healthy, Chronic Kidney Disease Trial in Birmingham (Diet)

      Completed
      • Healthy
      • Chronic Kidney Disease
      • Diet
      • Birmingham, Alabama
        University of Alabama
      Mar 10, 2021

      Selected Factors on Cardiovascular System in Chronic Kidney

      Completed
      • Atherosclerosis of Artery
      • +4 more
      • laboratory parameters - complete blood count
      • +23 more
      • Poznań, Poland
        Poznan University of Medical Sciences
      Jan 25, 2022

      Effect of rEPO in FGF23 in ESRD Patients

      Completed
      • Anemia
      • Chronic Kidney Diseases
      • Recombinant EPO
      • Santiago, Chile
        Hospital Clinico Universidad de Chile
      May 25, 2020

      Sepsis, Acute Kidney Injury Trial in Santiago

      Completed
      • Sepsis
      • Acute Kidney Injury
        • Santiago, RM, Chile
          University of Chile Clinical Hospital
        May 25, 2020

        Dent Disease Trial in Rochester (Phosphorus Supplement, Observation)

        Completed
        Has Results
        • Dent Disease
        • Phosphorus Supplement
        • Observation
        • Rochester, Minnesota
          Mayo Clinic
        Mar 19, 2020

        Plasma Concentrations of Calcium, Phosphate, FGF23, Klotho, 25

        Unknown status
        • Infertility, Female
        • Plasma level of vitamin D
        • Tübingen, Germany
          University Women's Hospital
        Feb 10, 2020

        Klotho as a Possible Biomarker of Peripheral Artery Disease

        Recruiting
        • Peripheral Arterial Disease
          • Rome, Italy
            Fondazione Policlinico Universitario A. Gemelli IRCCS
          Feb 24, 2023

          Carotid Stenosis, Carotid Endarterectomy Trial in Porto (Biomarker - FGF 23; troponin I; PCR - high sensitivity; BNP)

          Not yet recruiting
          • Carotid Stenosis
          • Carotid Endarterectomy
          • Biomarker - FGF 23; troponin I; PCR - high sensitivity; BNP
          • Porto, Portugal
            Faculdade de Medicina da Universidade do Porto
          Mar 26, 2020

          Hypophosphatemia, Hypophosphatemic Rickets, Pain, Chronic Trial in Clinton (Burosumab)

          Completed
          • Hypophosphatemia
          • +2 more
          • Burosumab
          • Clinton, Utah
            The Focus Center, PC
          Jan 14, 2020

          Markers of Metabolism and Vascular Access in ESRD

          Not yet recruiting
          • Disorders of Calcium and Bone Metabolism
          • vascular acess
          • (no location specified)
          May 2, 2023

          Fibroblast Growth Factor 23 and Sclerostin in Relation to

          Not yet recruiting
          • COVID-19
          • Calcium
          • +3 more
          • Aswan, Egypt
            Aswan University hospital
          Mar 11, 2022

          Fibroblast Growth Factor 23 in Chronic Respiratory Failure

          Not yet recruiting
          • Chronic Respiratory Failure
          • Dosage
          • Cardiac echography
          • (no location specified)
          Feb 17, 2022

          Role of Osteocytes in Myeloma Bone Disease

          Recruiting
          • Multiple Myeloma
            • Indianapolis, Indiana
            • +1 more
            Feb 8, 2022

            CKD Stage 5 Trial in Dallas (EffCaMgCit, CaAcS)

            Active, not recruiting
            • CKD Stage 5
            • Dallas, Texas
              DaVita Dialysis Centers
            Jan 20, 2023

            Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS), Epidermal Nevus Syndrome Trial in Washington (Burosumab)

            Active, not recruiting
            • Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)
            • Epidermal Nevus Syndrome
            • Washington, District of Columbia
              Children's National Hospital
            Mar 4, 2022